Africa's 32 Cents Solution for HIV/AIDS

This editorial discusses the issue of schistosomiasis in sub-Saharan Africa and believes that by preventing urogenital schistosomiasis in sexually active females through simple and low-cost methods there is an innovative and timely opportunity to reduce and possibly interrupt HIV/AIDS transmission throughout many rural areas of sub-Saharan Africa. It strongly advocates for the introduction of low-cost praziquantel mass drug administration in the PEPFAR countries of Mozambique Tanzania and Zambia by using PEPFAR funds in support of Schistosomiasis Control Initiative (SCI) activities through a Global Network for NTDs.